{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T16:56:31Z","timestamp":1781628991554,"version":"3.54.5"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":29,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hereditas"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and aims<\/jats:title>\n                    <jats:p>This study aims to investigate the effects of miR-4775 on pancreatic cancer cell (PC) invasion and migration, and to elucidate the underlying molecular mechanisms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Quantitative Real-Time Reverse Transcription (RT-qPCR) was performed to analyze miR-4775 and BRMS1L expression levels in both human PC tissues and human pancreatic carcinoma cells\u200c (PANC-1) lines. The prognostic value of miR-4775 in PC patients was evaluated through survival analysis. The CCK-8 assay was employed to assess cell viability, while Transwell assays were utilized to evaluate invasion and migration capabilities. The regulatory interaction between miR-4775 and BRMS1L was confirmed by dual-luciferase reporter assay.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Comparative analysis revealed significantly elevated miR-4775 expression in PC tissues versus adjacent normal tissues, with high miR-4775 expression correlating with poorer patient prognosis. Functional studies demonstrated that inhibition of miR-4775 significantly attenuated cellular viability, migration, and invasion capabilities, while knockdown of breast cancer metastasis suppressor 1-like\u200c (BRMS1L) effectively rescued these suppressive effects. The luciferase reporter assay confirmed a direct negative regulatory relationship between miR-4775 and its target gene BRMS1L.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These findings demonstrate that miR-4775 regulates PC progression by modulating cancer cell viability, migration, and invasion through BRMS1L-mediated mechanisms.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s41065-025-00619-w","type":"journal-article","created":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T02:53:44Z","timestamp":1767581624000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mechanistic insights into miR-4775-mediated regulation of pancreatic cancer cell invasion and migration through BRMS1L"],"prefix":"10.1186","volume":"163","author":[{"given":"Yaxi","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianli","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,5]]},"reference":[{"issue":"1","key":"619_CR1","first-page":"10","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A. Cancer statistics, 2025. CA Cancer J Clin. 2025;75(1):10\u201345.","journal-title":"CA Cancer J Clin"},{"key":"619_CR2","doi-asserted-by":"publisher","unstructured":"Cai J, Chen H, Lu M, Zhang Y, Lu B, You L, et al. Advances in the epidemiology of pancreatic cancer: Trends, risk factors, screening, and prognosis. Cancer Lett. 2021; 5201\u201311. https:\/\/doi.org\/10.1016\/j.canlet.2021.06.027.","DOI":"10.1016\/j.canlet.2021.06.027"},{"issue":"1","key":"619_CR3","doi-asserted-by":"publisher","first-page":"2129884","DOI":"10.1080\/08941939.2022.2129884","volume":"36","author":"HM Kolbeinsson","year":"2023","unstructured":"Kolbeinsson HM, Chandana S, Wright GP, Chung M. Pancreatic cancer: A review of current treatment and novel therapies. J Invest Surg. 2023;36(1):2129884.","journal-title":"J Invest Surg"},{"issue":"3","key":"619_CR4","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1053\/j.gastro.2020.10.007","volume":"160","author":"J Huang","year":"2021","unstructured":"Huang J, Lok V, Ngai CH, Zhang L, Yuan J, Lao XQ, et al. Worldwide burden of, risk factors for, and trends in pancreatic cancer. Gastroenterology. 2021;160(3):744\u201354.","journal-title":"Gastroenterology"},{"key":"619_CR5","doi-asserted-by":"publisher","unstructured":"Li X, Chen R, Li Z, Luo B, Geng W, Wu X. Diagnostic value of combining miRNAs, CEA measurement and the FOBT in colorectal cancer screening. Cancer Manag Res. 2020;122549\u201357. https:\/\/doi.org\/10.2147\/CMAR.S238492.","DOI":"10.2147\/CMAR.S238492"},{"issue":"2","key":"619_CR6","first-page":"521","volume":"56","author":"Z Lu","year":"2025","unstructured":"Lu Z, Li X, Li K, Yang S, Jiang F, Li S, et al. Expressions of miR-27a-3p mRNA and YAP1 mRNA in breast cancer and the relationship with clinicopathology and survival prognosis. Sichuan Da Xue Xue Bao Yi Xue Ban. 2025;56(2):521\u20137.","journal-title":"Sichuan Da Xue Xue Bao Yi Xue Ban"},{"issue":"2","key":"619_CR7","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.semcancer.2008.01.008","volume":"18","author":"AL Gartel","year":"2008","unstructured":"Gartel AL, Kandel ES, miRNAs. Little known mediators of oncogenesis. Semin Cancer Biol. 2008;18(2):103\u201310.","journal-title":"Semin Cancer Biol"},{"issue":"6","key":"619_CR8","first-page":"1170","volume":"52","author":"W Wei","year":"2023","unstructured":"Wei W, Wei X, Xie X. Linc01614 regulates the proliferation, apoptosis, and chemotherapy resistance in esophageal squamous cell carcinoma by targeting Mir-4775. Iran J Public Health. 2023;52(6):1170\u201380.","journal-title":"Iran J Public Health"},{"issue":"1","key":"619_CR9","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12943-017-0585-z","volume":"16","author":"S Zhao","year":"2017","unstructured":"Zhao S, Sun H, Jiang W, Mi Y, Zhang D, Wen Y, et al. Mir-4775 promotes colorectal cancer invasion and metastasis via the Smad7\/TGF\u03b2-mediated epithelial to mesenchymal transition. Mol Cancer. 2017;16(1):12.","journal-title":"Mol Cancer"},{"issue":"4","key":"619_CR10","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1016\/j.bbrc.2004.08.227","volume":"323","author":"AY Nikolaev","year":"2004","unstructured":"Nikolaev AY, Papanikolaou NA, Li M, Qin J, Gu W. Identification of a novel BRMS1-homologue protein p40 as a component of the mSin3A\/p33(ING1b)\/HDAC1 deacetylase complex. Biochem Biophys Res Commun. 2004;323(4):1216\u201322.","journal-title":"Biochem Biophys Res Commun"},{"issue":"13","key":"619_CR11","first-page":"5595","volume":"23","author":"Y Hu","year":"2019","unstructured":"Hu Y, Zhang Q, Cui J, Liao ZJ, Jiao M, Zhang YB, et al. Oncogene miR-934 promotes ovarian cancer cell proliferation and inhibits cell apoptosis through targeting BRMS1L. Eur Rev Med Pharmacol Sci. 2019;23(13):5595\u2013602.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"619_CR12","doi-asserted-by":"publisher","unstructured":"Gong C, Qu S, Lv XB, Liu B, Tan W, Nie Y, et al. BRMS1L suppresses breast cancer metastasis by inducing epigenetic silence of FZD10. Nat Commun. 2014;55406. https:\/\/doi.org\/10.1038\/ncomms6406.","DOI":"10.1038\/ncomms6406"},{"key":"619_CR13","doi-asserted-by":"publisher","unstructured":"Zhou R, Tang X, Li L, Zhang F, Sun J, Ju C, et al. Identification of BRMS1L as metastasis suppressing gene in esophageal squamous cell carcinoma. Cancer Manag Res. 2020;12531\u20139. https:\/\/doi.org\/10.2147\/CMAR.S232632.","DOI":"10.2147\/CMAR.S232632"},{"issue":"2","key":"619_CR14","doi-asserted-by":"publisher","first-page":"311","DOI":"10.3233\/CBM-171019","volume":"22","author":"J Lv","year":"2018","unstructured":"Lv J, Yang H, Wang X, He R, Ding L, Sun X. Decreased BRMS1L expression is correlated with glioma grade and predicts poor survival in glioblastoma via an invasive phenotype. Cancer Biomark. 2018;22(2):311\u20136.","journal-title":"Cancer Biomark"},{"key":"619_CR15","doi-asserted-by":"publisher","unstructured":"Liu Y, Fan X, Zhao Z, Shan X. LncRNA SLC7A11-AS1 contributes to lung cancer progression through facilitating TRAIP expression by inhibiting miR-4775. Onco Targets Ther. 2020;136295\u2013302. https:\/\/doi.org\/10.2147\/OTT.S253082.","DOI":"10.2147\/OTT.S253082"},{"issue":"7","key":"619_CR16","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1053\/j.gastro.2019.01.259","volume":"156","author":"AD Singhi","year":"2019","unstructured":"Singhi AD, Koay EJ, Chari ST, Maitra A. Early detection of pancreatic cancer: opportunities and challenges. Gastroenterology. 2019;156(7):2024\u201340.","journal-title":"Gastroenterology"},{"key":"619_CR17","doi-asserted-by":"crossref","unstructured":"Adamska A, Domenichini A, Falasca M. Pancreatic ductal adenocarcinoma: current and evolving therapies. Int J Mol Sci. 2017;18(7):1338.","DOI":"10.3390\/ijms18071338"},{"issue":"5","key":"619_CR18","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646\u201374.","journal-title":"Cell"},{"issue":"12","key":"619_CR19","doi-asserted-by":"publisher","first-page":"7438","DOI":"10.1074\/jbc.M709446200","volume":"283","author":"DR Hurst","year":"2008","unstructured":"Hurst DR, Xie Y, Vaidya KS, Mehta A, Moore BP, Accavitti-Loper MA, et al. Alterations of BRMS1-ARID4A interaction modify gene expression but still suppress metastasis in human breast cancer cells. J Biol Chem. 2008;283(12):7438\u201344.","journal-title":"J Biol Chem"},{"key":"619_CR20","doi-asserted-by":"publisher","unstructured":"Hao J, Jin X, Shi Y, Zhang H. miR-93-5p enhance lacrimal gland adenoid cystic carcinoma cell tumorigenesis by targeting BRMS1L. Cancer Cell Int. 2018;1872. https:\/\/doi.org\/10.1186\/s12935-018-0552-9.","DOI":"10.1186\/s12935-018-0552-9"},{"issue":"22","key":"619_CR21","doi-asserted-by":"publisher","first-page":"13812","DOI":"10.1074\/jbc.M115.653261","volume":"290","author":"W Zhang","year":"2015","unstructured":"Zhang W, Qian P, Zhang X, Zhang M, Wang H, Wu M, et al. Autocrine\/paracrine human growth hormone-stimulated MicroRNA 96-182-183 cluster promotes epithelial-mesenchymal transition and invasion in breast cancer. J Biol Chem. 2015;290(22):13812\u201329.","journal-title":"J Biol Chem"}],"container-title":["Hereditas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41065-025-00619-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41065-025-00619-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41065-025-00619-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T16:06:02Z","timestamp":1781625962000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s41065-025-00619-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,5]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["619"],"URL":"https:\/\/doi.org\/10.1186\/s41065-025-00619-w","relation":{},"ISSN":["1601-5223"],"issn-type":[{"value":"1601-5223","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,5]]},"assertion":[{"value":"1 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Harbin Traditional Chinese Medicine Hospital before the study began. The written informed consent has been obtained from the participants involved.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20"}}